Follow-Up Study of Malaria Vaccines in Kenyan Children
Author Information
Author(s): Bejon Philip, Ogada Edna, Mwangi Tabitha, Milligan Paul, Lang Trudie, Fegan Greg, Gilbert Sarah C., Peshu Norbert, Marsh Kevin, Hill Adrian V.S.
Primary Institution: Kenya Medical Research Institute, Centre for Geographical Medicine Research (Coast), Kilifi, Kenya
Hypothesis
Does the FFM ME-TRAP malaria vaccine provide protection against malaria in children?
Conclusion
The FFM ME-TRAP vaccine did not provide protection against malaria, with similar incidence rates in both vaccine and control groups.
Supporting Evidence
- The incidence of malaria was slightly higher in children who received the vaccine, but this was not statistically significant.
- During the 18 months of monitoring, there were 63 malaria events in the vaccine group and 60 in the control group.
- The hazard ratio for the effect of vaccination was 1.2, indicating no significant difference in malaria incidence.
Takeaway
The study tested a malaria vaccine on kids in Kenya, but it didn't help them avoid getting malaria any better than a regular vaccine.
Methodology
The study was a randomized, controlled, double-blind trial with follow-up monitoring for 18 months.
Potential Biases
Potential bias due to unblinding and the influence of knowledge about vaccine allocation on health-seeking behavior.
Limitations
The study was unblinded after the first 9 months, which may have influenced health-seeking behavior.
Participant Demographics
Children aged 1-6 years from rural Kenya.
Statistical Information
P-Value
0.35
Confidence Interval
0.84-1.73
Statistical Significance
p=0.35
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website